Quick Answer
ENDRA Life Sciences Inc. reported Shares Outstanding of 1.18 million shares for fiscal year 2025.
ENDRA Life Sciences Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 1.18M | +119.1% |
| 2024 | 536,908 | +8943.4% |
| 2023 | 5,937 | -99.8% |
| 2022 | 3.17M | +48.9% |
| 2021 | 2.13M | -93.8% |
| 2020 | 34.05M | +304.3% |
| 2019 | 8.42M | +13.5% |
| 2018 | 7.42M | +89.2% |
| 2017 | 3.92M | +442.4% |
| 2016 | 723,335 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 786,902 | — | +4.6% |
| June 30, 2025 | 752,390 | -99.0% | +33.8% |
| March 31, 2025 | 562,213 | -94.8% | +4.7% |
| December 31, 2024 | 536,908 | -94.8% | -99.3% |
| June 30, 2024 | 72.44M | +868.2% | +563.7% |
| March 31, 2024 | 10.91M | +244.4% | +5.0% |
| December 31, 2023 | 10.39M | +227.9% | +23.5% |
| September 30, 2023 | 8.41M | -86.7% | +12.4% |
- ENDRA Life Sciences Inc. showed an increase of +119.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2016–2025 period, ENDRA Life Sciences Inc.’s shares outstanding has grown by 62.6% (from 723.3 thousand shares to 1.18 million shares).
- The most recent figure is from ENDRA Life Sciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: